SEO Software: Trying To Catch The Spiders…

SEO software does what exactly?SEO software frequently starts from the following assumption:- look at the page that ranks number 1 in Google,- do exactly the same + a bit better,- and you will be number 1SEO software will then examine “all” the SEO parameters that it finds out about the number 1 site in Google. Then this SE software will automate the process in mimicking this for your site.SEO is more than a software-approach!SEO is the art of ranking number 1 in any search engine for any keyword.Spiders rank a web site number one because spiders “think” that this site deserves to be number one. Of course the spider cannot think: there needs to be a programmer who programs the spider to find out which site is best.Now if you are smart enough to feed the spider exactly what the programmer thinks is important, you will have the knowledge to rank number 1.This is exactly what SEO software does: it claims to know and tackle “all” the parameters that make a web site ranking number 1.Pitfalls of a software-approach to SEOSuppose you find all the parameters needed to rank a web site number 1. You manage to get all this parameters onto your site and you even manage to be rank number 1.Now if your site is really deserving to be ranked number 1, all is fine. But if surfers start complaining that you are not, the search engine will be blamed!It won’t take long until Google finds out that “somebody broke the code” of the spiders. The spiders will be updated to give quality results to the visitors!This means you need to get an upgrade of your SEO software approach… : you are running after the facts in stead of above the facts.How to be ranked number 1?You rank number 1 because you deserve it.In spider logic this still means:- your page talks about the keyword you are optimizing for- you page has lots of incoming links about the keyword you are optimizing for.This is what ranking number 1 should be about.But my SEO software is really up to date, or is it not?Your software can only be up to date AFTER the spiders’ software is updated. Unless you write the spiders yourself, you will always be a bit later.You cannot know all the parameters the spider takes into account, unless again you are writing the spider software yourself.Some of the parameters you cannot influence: age of the web site is one of them. Suppose the spider needs to choose between 2 websites: the oldest one and the SEO mimic: which one to choose? The oldest one would be the easiest bet, and you cannot change the age of your web site can you?A close look at SEO softwareSEO software advertisements could say that you can get a top 5 Google Ranking in under 30 Days… If that is true, then check out to see:- is the web site of this SEO software ranking number 1 in Google for SEO or SEO software?- are the example web sites the SEO software mentions to be ranked number 1, really number 1: number 1 in Google that is?It’s very easy to type in the keyword phrase of the SEO software example web site and see if they are number 1 or not.And don’t be fooled by SEO software that gives numerous examples of number 1 rankings in MSN or Yahoo: if you want to have a long lasting number 1 ranking in any of the search engines, you better start having a number 1 ranking in Google.I didn’t say that it is a guarantee to rank number 1 in Yahoo and MSN once you rank number 1 in Google, but you will surely be high up there as well. On the other hand, a number 1 ranking in MSN can mean that you are no where to be found in Yahoo nor Google.So you say: well, then I just try to rank number 1 in MSN since it seems to be easier. Well, it is easier, but then it is easier for your competition as well, so it won’t take then too much effort to out-play you again. Therefor do the job good once and for all: thrive to be number 1 in Google and then fine-tune if needed for MSN or Yahoo.Why do you do SEO in the first place?SEO is 1 of the ways to get more traffic to your web site. But there is more in getting a lot of traffic to your site, than “blindly ranking 1 in Google”:— Always make sure you rank number 1 for a word a lot of people are looking for! —If you buy any SEO software or out-source your SEO to the SEO specialists: always check their SEO examples:- are they ranking number 1- are the keywords they rank for popular search keywords (bigger than 10.000 searches a month in the Keyword Selector Tool from Yahoo’s search-marketing is considered not too low)- how long did it take them to be number 1- how big is the competition for the keyword-phrase (smaller or bigger than 5 million? As a general rule : above 5 million keyword-phrase results in Google, things become though)- how big is the competition for the quoted “keyword-phrase” (smaller or bigger than 33.000? As a general rule : above 33.000 quoted “keyword-phrase” results in Google, things become though)If for all these items the SEO software or SEO specialist can answer YES, then you can start taking them very seriously!Try it out for each example web site any SEO software claims to have ranked number 1 for a certain keyword-phrase. And of course, always start with checking if they are ranking number 1 in the first place! If they are not, then you are going to buy SEO software that doesn’t do the job! Ranking number 2 is ALMOST number 1, and even worse, ranking number 9 is nowhere near to ranking number 1.SEO software web sitesWhenever you are interested in something to buy on the Internet, check out the overall web site of the product you want to buy!Some SEO software web sites are 1 page web sites: just 1 page with the product, no links, no extra pages…Again back to basics. What was the first idea to set up the Internet? To give people information, lots of information.And we are talking about a “NET” in Inter”NET”: “net” means links here, links there, links everywhere… (that’s why links are so important in SEO)If you don’t see lots of links nor lots of content on a web site about SEO, then the SEO web site is not serious about its own subject: SEO!Back to Basics: web-trafficYour purpose is getting as much people to your site as possible, isn’t it?SEO software has the purpose of ranking 1 in Google.Now it is very easy to rank 1 in Google for the keyword-phrase “jhdkghgkbdcds”,
but who is looking for “jhdkghgkbdcds”??? Nobody!So if nobody looks for “jhdkghgkbdcds”, then why bother to rank number 1 with it?What is a nice number when it comes to “popular keyword searches”? If you use the Overture Keyword tool, anything above 10.000 searches a month means quite popular, but: also know that above 10.000 “the big boys’ are competing
with you, below 1.000 you have the field for yourself. So a good SEO advice is work yourself from the bottom up: start with keywords that are not so popular, and once you are ranked high for those, then tackle the next more popular keyword on the list.SEO software ConclusionSEO is the art to feed the spiders what they like.
SEO software is running after the spiders trying to catch their attention.Always check the numbers and the facts about any SEO software and (this) SEO article!Then make a decision yourself. If you see that the SEO software- is ranking well for it’s own product- is ranking web sites for popular keyword well,only then you can consider buying it.

S&P 500 Biotech Giant Vertex Leads 5 Stocks Showing Strength

Your stocks to watch for the week ahead are Cheniere Energy (LNG), S&P 500 biotech giant Vertex Pharmaceuticals (VRTX), Cardinal Health (CAH), Steel Dynamics (STLD) and Genuine Parts (GPC).

X
While the market remains in correction, with analysts and investors wary of an economic downturn, these five stocks are worth adding to watchlists. S&P 500 medical giants Vertex and Cardinal Health have been holding up, as health-care related plays tend to do well in down markets.

Steel Dynamics and Genuine Parts are both coming off strong earnings as both the steel and auto parts industries report optimistic outlooks. Meanwhile, Cheniere Energy saw sales boom in the second quarter as demand in Europe for natural gas continues to grow.

Major indexes have been making rally attempts with the Dow Jones and S&P 500 testing weekly support on Friday. With market uncertainty, investors should be ready for follow-through day breakouts and keep an eye on these stocks.

Cheniere Energy, Cardinal Health and VRTX stock are all on IBD Leaderboard.

Cheniere Energy Stock
LNG shares rose 1.1% to 175.79 during Friday’s market trading. On the week, the stock advanced 3.1%, not from highs, bouncing from its 21-day and 10-week lines earlier in the week.

Cheniere Energy has been consolidating since mid-September, but needs another week to forge a proper base, with a potential 182.72 buy point formed on Aug. 10.

Houston-based Cheniere Energy was IBD Stock Of The Day on Thursday, as the largest U.S. producer of liquefied natural gas eyes strong demand in Europe.

Even though natural gas prices are plunging in the U.S. and Europe, investors still see strong LNG demand for Cheniere and others.

The U.K. government confirmed last week that it is in talks for an LNG purchase agreement with a number of companies, including Cheniere.

In the first half of 2021, less than 40% of Cheniere’s cargoes of LNG landed in Europe. That jumped to more than 70% through this year’s second quarter, even as the company ramped up new export capacity. The urgency of Europe’s natural gas shortage only intensified last month. That is when an explosion disabled the Nord Stream 1 pipeline from Russia that had once supplied 40% of the European Union’s natural gas.

In Q2, sales increased 165% to $8 billion and LNG earned $2.90 per share, up from a net loss of $1.30 per share in Q2 2021. The company will report Q3 earnings Nov. 3, with investors seeing booming profits for the next few quarters.

Cheniere Energy has a Composite Rating of 84. It has a 98 Relative Strength Rating, an exclusive IBD Stock Checkup gauge for share price movement with a 1 to 99 score. The rating shows how a stock’s performance over the last 52 weeks holds up against all the other stocks in IBD’s database. The EPS rating is 41.

Vertex Stock
VRTX stock jumped 3.4% to 300 on Friday, rebounding from a test of its 50-day moving average. Shares climbed 2.2% for the week. Vertex stock has formed a tight flat base with an official buy point of 306.05, according to MarketSmith analysis.

The stock has remained consistent over recent weeks, while the relative strength line has trended higher. The RS line tracks a stock’s performance vs. the S&P 500 index.

Vertex Q3 earnings are on due Oct. 27. Analysts see EPS edging up 1% to $3.61 per share with sales increasing 16% to $2.2 billion, according to FactSet.

The Boston-based global biotech company dominates the cystic fibrosis treatment market. Vertex also has other products in late-stage clinical development that target sickle cell disease, Type 1 diabetes and certain genetically caused kidney diseases. That includes a gene-editing partnership with Crispr Therapeutics (CRSP).

In early August, Vertex reported better-than-expected second-quarter results and raised full-year sales targets.

S&P 500 stock Vertex ranks second in the Medical-Biomed/Biotech industry group. VRTX has a 99 Composite Rating. Its Relative Strength Rating is 94 and its EPS Rating is 99.

CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?

Cardinal Health Stock
CAH stock advanced 3.2% to 73.03 Friday, clearing a 71.22 buy point from a shallow cup-with-handle base and hitting a record high. But volume was light on the breakout. CAH stock leapt 7.3% for the week.

Cardinal Health stock’s relative strength line has also been trending up for months.

The cup-with-handle base is part of a base-on-base pattern, forming just above a cup base cleared on Aug. 11.

Cardinal Health, based in Dublin, Ohio, offers a wide assortment of health care services and medical supplies to hospitals, labs, pharmacies and long-term care facilities. The company reports that it serves around 90% of hospitals and 60,000 pharmacies in the U.S.

S&P 500 stock Cardinal Health will report Q1 2023 earnings on Nov. 4. Analysts forecast earnings falling 26% to 96 cents per share. Sales are expected to increase 10% to $48.3 billion, according to FactSet.

Cardinal Health stock ranks first in the Medical-Wholesale Drug/Supplies industry group, ahead of McKesson (MCK), which is also showing positive action. CAH stock has a 94 Composite Rating out of 99. It has a 97 Relative Strength Rating and an EPS rating of 73.

Steel Dynamics Stock
STLD shares shot up 8.5% to 92.92 on Friday and soared 19% on the week, coming off a Steel Dynamics earnings beat Wednesday night.

Shares blasted above an 88.72 consolidation buy point Friday after clearing a trendline Thursday. STLD stock is 17% above its 50-day line, definitely extended from that key average.

Steel Dynamics’ latest consolidation could be seen as part of a larger base going back six months.

Steel Dynamics topped Q3 earnings views with EPS rising 10% to $5.46 while revenue grew 11% to $5.65 billion. The steel producer’s outlook is optimistic despite weaker flat rolled steel pricing. STLD reports its order activity and backlogs remain solid.

The Fort Wayne, Indiana-based company is among the largest producers of carbon steel products in the U.S. It engages in metal recycling operations along with steel fabrication and produces myriad steel products.

How Millett Grew Steel Dynamics From A Three Employee Business

STLD stock ranks first in the Steel-Producers industry group. STLD stock has a 96 Composite Rating out of 99. It has a 90 Relative Strength Rating, an exclusive IBD Stock Checkup gauge for share-price movement that tops at 99. The rating shows how a stock’s performance over the last 52 weeks holds up against all the other stocks in IBD’s database. The EPS rating is 98.

Genuine Parts Stock
GPC stock gained 2.8% to 162.35 Friday after the company topped earnings views with its Q3 results on Thursday. For the week GPC advanced 5.1% as the stock held its 50-day line and is in a flat base.

GPC has an official 165.09 flat-base buy point after a three-week rally, according to MarketSmith analysis.

The relative strength line for Genuine Parts stock has rallied sharply to highs over the past several months.

On Thursday, the Atlanta-based auto parts company raised its full-year guidance on growth across its automotive and industrial sales.

Genuine Parts earnings per share advanced 19% to $2.23 and revenue grew 18% to $5.675 billion in Q3. GPC’s full-year guidance is now calling for EPS of $8.05-$8.15, up from $7.80-$7.95. The company now forecasts revenue growth of 15%-16%, up from the earlier 12%-14%.

During the Covid pandemic, supply chain constraints caused a major upheaval in the auto industry, sending prices for new and used cars to record levels. This has made consumers more likely to hang on to their existing vehicles for longer, driving mileage higher and boosting demand for auto replacement parts.

Fellow auto stocks O’Reilly Auto Parts (ORLY) and AutoZone (AZO) have also rallied near buy points amid the struggling market. O’Reilly reports on Oct. 26.

IBD ranks Genuine Parts first in the Retail/Wholesale-Auto Parts industry group. GPC stock has a 96 Composite Rating. Its Relative Strength Rating is 94 and it has an EPS Rating of 89.

S&P 500 Rallies As U.S. Dollar Pulls Back Towards Weekly Lows

Key Insights
The strong pullback in the U.S. dollar provided significant support to stocks.
Treasury yields have pulled back after touching new highs, which served as an additional positive catalyst for S&P 500.
A move above 3730 will push S&P 500 towards the resistance level at 3760.
Advertisement

Pfizer Rallies After Announcing A Huge Price Hike For Its COVID-19 Vaccines
S&P 500 is currently trying to settle above 3730 as traders’ appetite for risk is growing. The U.S. dollar has recently gained strong downside momentum as the BoJ intervened to stop the rally in USD/JPY. Weaker U.S. dollar is bullish for stocks as it increases profits of multinational companies and makes U.S. equities cheaper for foreign investors.

The leading oil services company Schlumberger is up by 9% after beating analyst estimates on both earnings and revenue. Schlumberger’s peers Baker Hughes and Halliburton have also enjoyed strong support today.

Vaccine makers Pfizer and Moderna gained strong upside momentum after Pfizer announced that it will raise the price of its coronavirus vaccine to $110 – $130 per shot.

Biggest losers today include Verizon and Twitter. Verizon is down by 5% despite beating analyst estimates on both earnings and revenue. Subscriber numbers missed estimates, and traders pushed the stock to multi-year lows.

Twitter stock moved towards the $50 level as the U.S. may conduct a security review of Musk’s purchase of the company.

From a big picture point of view, today’s rebound is broad, and most market segments are moving higher. Treasury yields have started to move lower after testing new highs, providing additional support to S&P 500. It looks that some traders are ready to bet that Fed will be less hawkish than previously expected.

S&P 500 Tests Resistance At 3730

S&P 500 has recently managed to get above the 20 EMA and is trying to settle above the resistance at 3730. RSI is in the moderate territory, and there is plenty of room to gain additional upside momentum in case the right catalysts emerge.

If S&P 500 manages to settle above 3730, it will head towards the next resistance level at 3760. A successful test of this level will push S&P 500 towards the next resistance at October highs at 3805. The 50 EMA is located in the nearby, so S&P 500 will likely face strong resistance above the 3800 level.

On the support side, the previous resistance at 3700 will likely serve as the first support level for S&P 500. In case S&P 500 declines below this level, it will move towards the next support level at 3675. A move below 3675 will push S&P 500 towards the support at 3640.